跳到正文
原文
Nature 健康护理主题·· 18 天前AI 评分35

CHARLS 研究揭示高温暴露与呼吸肌少症发生的关系

Heatwave exposure and respiratory sarcopenia incidence in a Chinese cohort

AI 导读

一项基于中国 CHARLS 研究队列的研究发现,高温暴露与呼吸肌少症的发生存在关联。研究纳入 1984 名中老年人,通过比较 2011 年和 2015 年的高温日数,分析了不同高温定义下的暴露变化。研究结果表明,高温暴露可能增加呼吸肌少症的风险,但具体机制尚需进一步研究。

正文

Introduction

Climate change has intensified the frequency and severity of heatwaves globally, posing substantial threats to human health1,2. Epidemiological studies have linked heatwave exposure to cardiovascular and respiratory morbidity and mortality, including outpatient visits for respiratory diseases, cardiorespiratory mortality, and acute heat-related illness, particularly among older adults and people with chronic diseases3,4,5,6,7,8. Respiratory sarcopenia, characterized by reduced respiratory muscle strength with or without low muscle mass, is an emerging concern in aging populations9. It is associated with reduced lung function, frailty, and adverse clinical outcomes, yet its environmental determinants remain poorly understood10,11.

Previous research on heatwaves has mainly focused on mortality, hospitalization, respiratory symptoms, and lung function, whereas research on sarcopenia has primarily examined aging, chronic disease, nutrition, and physical function3,4,5,6,7,9,10,11,12,13. Direct studies connecting heatwave exposure with sarcopenia, especially respiratory sarcopenia, remain scarce. Heat stress may plausibly affect respiratory muscle-related health through dehydration, systemic inflammation, oxidative stress, reduced physical activity, sleep disruption, or increased ventilatory demand, but these pathways have not been well tested in population-based longitudinal cohorts3,4,5,6,8,14,15,16,17,18.

Important uncertainties therefore remain regarding whether heatwave exposure is associated with incident respiratory sarcopenia, whether any association is consistent across heatwave definitions and durations, and which groups may be more susceptible.

We aimed to investigate the association between heatwave exposure and incident respiratory sarcopenia in a prospective cohort. We also sought to identify potentially susceptible subpopulations and assess the robustness of findings through sensitivity analyses.

Methods

Population

This study utilized data from the CHARLS, a prospective, nationally representative cohort study conducted in China. A detailed description of the CHARLS project has been reported elsewhere19. In this study, the first wave of CHARLS (2011) was considered the baseline, and the third wave (2015) served as the follow-up survey. Participants younger than 45 years were excluded because CHARLS was designed to represent middle-aged and older adults in China, and respiratory sarcopenia is primarily an age-related condition. Of 25,586 initially selected CHARLS records, we excluded participants with missing sex (n = 4660), participants who could not be linked to residence or city location data (n = 4619), participants without matched city-level meteorological station information (n = 9568), participants from city_code 4100 (n = 27), participants with missing diagnostic variables for respiratory sarcopenia (n = 3628), and participants younger than 45 years (n = 111). Among the remaining 2973 participants, 989 with probable or confirmed respiratory sarcopenia at baseline were further excluded to focus on incident cases, leaving 1,984 participants in the final analytic cohort (Fig. 1). Proxy interview status was not used as an exclusion criterion in the analytic cohort. Therefore, where CHARLS permitted proxy reporting, some self-reported covariates may have been provided by proxy respondents rather than directly by participants. Due to the unavailability of participants’ exact residential addresses, environmental exposure was assessed at the city level. Table S1 illustrates the distribution of survey sites. It was assumed that participants residing in the same city shared identical exposure levels and that their residences remained relatively stable. These assumptions are partly supported by the participants’ age and China’s Hukou household registration system, although residual exposure misclassification remains possible. All participants provided informed consent, and the protocol was approved by the Ethical Review Committee of Peking University (IRB00001052-11015). The dataset used in this study is publicly available.

Fig. 1

Study population flow diagram. The flow diagram shows the selection of the final analytic cohort from the initial CHARLS records, including exclusions for missing linkage information, missing diagnostic variables, age < 45 years, and baseline probable or confirmed respiratory sarcopenia.

Covariates

The study collected baseline characteristics of participants in 2011, including age, sex, body mass index (BMI), education level, residence, geographic region (delineated by the Qinling-Huaihe line), history of alcohol consumption, smoking history, marital status, physical activity level, and presence of chronic lung disease (including asthma). Additionally, changes in BMI, alcohol consumption status, smoking status, and physical activity status were assessed over the study period to capture dynamic shifts in these key variables.

Diagnostic algorithm for respiratory sarcopenia

Respiratory sarcopenia was defined based on the current consensus that sarcopenia is a generalized muscle disorder characterized by the loss of muscle strength and mass9,12,13. Peak expiratory flow rate (PEFR) was used as a surrogate indicator of respiratory muscle strength because direct measures such as maximal inspiratory or expiratory pressure were unavailable in CHARLS. We adopted PEFR cut-off values (4.40 L/s for men and 3.21 L/s for women) proposed by a previous Asian-population study20. PEFR is clinically relevant to respiratory muscle performance but may also be influenced by airway obstruction, chronic pulmonary disease, acute respiratory status, and participant effort; therefore, the outcome in this study should be interpreted as PEFR-based respiratory sarcopenia. Appendicular skeletal muscle mass (ASM) was estimated using a validated anthropometric equation suitable for the Chinese population21,22. Multiple studies have demonstrated strong concordance between ASM equation models and dual-energy X-ray absorptiometry21,22,23. Cutoff values for low muscle mass were defined as the sex-specific values within the lowest 20% of the study population at baseline, adjusted for height (Ht) (ASM/Ht2)22,24. Probable respiratory sarcopenia was defined by the presence of a low PEFR. Confirmed respiratory sarcopenia was established in these individuals by the additional finding of low appendicular skeletal muscle mass adjusted for height (ASM/Ht2). Based on the occurrence of respiratory sarcopenia from 2011 to 2015, participants were categorized into two groups: the group with incident respiratory sarcopenia (IRS Group) and the group without incident respiratory sarcopenia (Non-IRS Group). The IRS Group included participants who developed respiratory sarcopenia during the follow-up period, progressing from no respiratory sarcopenia at baseline to either probable respiratory sarcopenia or confirmed respiratory sarcopenia. All other participants, who remained free of respiratory sarcopenia throughout the follow-up, were classified into the Non-IRS Group.

Assessment of heatwave

The meteorological data during the study period (daily average dew point temperature and daily average temperature) were sourced from the China Meteorological Administration Land Data Assimilation System (CLDAS version 2.0)25,26,27. We used the weathermetrics package in R software (version 4.4.2) to calculate the daily average heat index (HI). Since there is no standard definition for heatwaves, we defined heatwaves based on the combination of heatwave intensity and duration proposed in previous studies. Therefore, based on existing literature23, we determined the daily average HI relative thresholds (90th, 92.5th, 95th, and 97.5th percentiles) for specific cities during the study period. These thresholds were then paired with different heatwave durations: >  = 2 days, >  = 3 days, and >  = 4 days. This combination resulted in 12 heatwave definitions (Table 1). Specifically, we calculated the change in exposure during the study period by comparing the number of heatwave days or events experienced by an individual in the 11 months prior to the interview month and the survey month in 2015 with the number experienced in the comparable period in 2011. Table 2 illustrates the changes in heatwave exposure during follow-up. Because exact residential addresses were unavailable, environmental exposure was assessed at the city level. This approach may not capture individual-level variation in indoor temperature, time-activity patterns, air conditioning use, occupational exposure, or short-term mobility. Negative values in Table 2 indicate that, for a given city-specific definition and participant interview window, the number of heatwave events or days in the 2015 exposure window was lower than that in the comparable 2011 window. These values should therefore be interpreted as within-participant changes between two survey-linked exposure windows rather than as a national monotonic trend in heatwave intensity or duration.

Table 1 Heatwaves definitions in the present study.

Full size table

Table 2 Changes in heatwave exposure during follow-up.

Full size table

Statistical analysis

Baseline characteristics were summarized based on respiratory sarcopenia status (IRS Group and Non-IRS Group) and compared between participants using the chi-squared test or the Kruskal–Wallis test, as appropriate. Data are presented as means ± standard deviation (SD) or median and interquartile range (IQR) for continuous variables and percentages for categorical variables. Multiple logistic regression analyses were conducted to assess the association between heatwave exposures and binary respiratory sarcopenia status using three stepwise models. Model 1 was an unadjusted analysis evaluating the crude association. Model 2 adjusted for Covariate Set A, including age, sex, BMI, marital status, education level, residence, history of alcohol consumption, smoking history, geographic region, mean heat index, and physical activity level. Model 3 adjusted for Covariate Set B, which included all variables in Covariate Set A plus chronic lung disease, change in BMI, and changes in drinking, smoking, and physical activity status. To reduce interpretive ambiguity from multiple heatwave definitions, the main interpretation focused on the fully adjusted model and on the consistency, direction, and magnitude of associations across definitions rather than isolated significant results from individual definitions. The 95th percentile threshold lasting >  = 2 consecutive days (HW07) was treated as the primary heatwave definition because it represents a commonly used high-temperature threshold while retaining sufficient exposure variability; the remaining definitions were considered robustness analyses. We performed weighted logistic regressions stratified by age, sex, BMI, geographic region, and chronic lung disease status to examine subgroup patterns. Interaction terms were tested to assess whether these associations varied across subgroups. To assess the robustness of the key findings, we conducted sensitivity analyses by excluding participants with missing baseline characteristics or standardizing age and BMI. No additional lag-period models were fitted because the exposure metric was defined over the survey month and preceding 11 months in each wave, which was intended to capture medium-term exposure before assessment. Therefore, shorter disease-latency windows or delayed effects could not be separately evaluated.

Results

Characteristics of participants

Table 3 shows the characteristics of participants by respiratory sarcopenia status. The median age of the study population was 56 years (IQR, 50–62), and 1266 (63.8%) were female. Among 1984 middle-aged to older adults, 15.7% developed respiratory sarcopenia during follow-up. Compared with participants in the Non-IRS Group, those in the IRS Group were older (median age, 58 versus 56 years), had a higher proportion of males (68.2% versus 30.2%), and were more likely to have less than lower secondary education (93.6% versus 88.0%) or chronic lung disease (15.4% versus 7.5%). Additionally, participants in the IRS Group were less likely to have a history of alcohol consumption (32.5% versus 53.0%) or smoking (30.9% versus 52.7%) than those in the Non-IRS Group.

Table 3 Baseline characteristics of study population.

Full size table

Association between heatwave exposure and respiratory sarcopenia

Figure 2 and Figure S1 illustrate the association between heatwave exposure and respiratory sarcopenia status. In the fully adjusted model 3, greater heatwave frequency was associated with higher odds of respiratory sarcopenia across five definitions [odds ratio (OR) 1.120, 95% confidence interval (CI) 1.033–1.214 for HW07; OR 1.127, 95% CI 1.026–1.238 for HW08; OR 1.128, 95% CI 1.012–1.258 for HW09; OR 1.136, 95% CI 1.031–1.253 for HW10; OR 1.199, 95% CI 1.049–1.369 for HW11] (Fig. 2A). Similarly, an increase in heatwave days was associated with higher odds of incident respiratory sarcopenia across eleven definitions (OR 1.017, 95% CI 1.004–1.030 for HW01; OR 1.017, 95% CI 1.003–1.032 for HW02; OR 1.014, 95% CI 1.001–1.027 for HW03; OR 1.026, 95% CI 1.011–1.042 for HW04; OR 1.025, 95% CI 1.009–1.041 for HW05; OR 1.025, 95% CI 1.010–1.041 for HW06; OR 1.021, 95% CI 1.007–1.036 for HW07; OR 1.019, 95% CI 1.005–1.034 for HW08; OR 1.018, 95% CI 1.004–1.033 for HW09; OR 1.019, 95% CI: 1.004–1.034 for HW10; OR 1.020, 95% CI: 1.004–1.037 for HW11) (Fig. 2B). Given the use of multiple heatwave definitions, these results should be interpreted primarily as evidence of a consistent exposure–response pattern rather than as independent findings for each definition. The associations were generally more consistent for heatwave days than for heatwave events, suggesting that the duration or cumulative burden of heat exposure may be more informative than event counts alone. However, because definitions combined both percentile thresholds and minimum duration criteria, the results should be interpreted as patterns across related exposure metrics rather than as evidence that a single duration threshold is uniquely causal.

Fig. 2

Association between heatwave exposure and respiratory sarcopenia in Model 3: (A) heatwave events, (B) heatwave days. Association between heatwave exposure and change in PEFR in Model 3: (C) heatwave events, (D) heatwave days. OR, odds ratio; CI, confidence interval; PEFR, peak expiratory flow rate.

Impact of heatwave exposure on respiratory function and muscle mass

Figure 2C and D illustrate the association between heatwave exposure and change in PEFR. In the fully adjusted model 3, greater heatwave frequency was associated with lower PEFR under several definitions (estimate = 0.959, 95% CI 0.924–0.996 for HW02; estimate = 0.912, 95% CI 0.861–0.966 for HW10; estimate = 0.899, 95% CI 0.831–0.973 for HW11; estimate = 0.885, 95% CI 0.801–0.979 for HW12) (Fig. 2C). Similarly, an increase in heatwave days was associated with lower PEFR under several definitions (estimate = 0.991, 95% CI 0.983–0.999 for HW02; estimate = 0.988, 95% CI 0.979–0.997 for HW04; estimate = 0.986, 95% CI: 0.977–0.995 for HW05; estimate = 0.989, 95% CI 0.980–0.998 for HW06; estimate = 0.991, 95% CI 0.982–0.999 for HW07; estimate = 0.990, 95% CI 0.981–0.999 for HW09; estimate = 0.989, 95% CI 0.979–0.998 for HW10; estimate = 0.989, 95% CI 0.979–0.999 for HW11) (Fig. 2D). However, the impact of heatwaves on muscle mass appeared less pronounced (Figure S2). In the fully adjusted model 3, greater heatwave frequency was associated with lower muscle mass under only two definitions (estimate = 0.912, 95% CI 0.847–0.982 for HW01; estimate = 0.887, 95% CI 0.797–0.987 for HW02) (Figure S2A), while its impact appeared less evident across the remaining definitions. These analyses support a possible role of lung-function-related pathways, but they do not establish mediation or causality.

Subgroup analysis and sensitivity analysis

To identify subpopulations potentially susceptible to heatwave exposure, we performed subgroup analysis of the associations between heatwave exposure and the odds of respiratory sarcopenia, stratified by age, sex, BMI, geographic region, and chronic lung disease status (Table S2–11). Compared with participants with a BMI of 23 or higher, those with a BMI below 23 showed stronger positive associations between increased heatwave exposure and respiratory sarcopenia risk [estimate = 0.311, 95% CI 0.078–0.545 versus estimate = − 0.112, 95% CI − 0.359–0.135 for HW12 (events)] (Table S6). Participants with chronic lung disease also appeared more susceptible to heatwave exposure [estimate = 0.147, 95% CI 0.025–0.270 versus estimate = 0.007, 95% CI − 0.040–0.053 for HW01 (events); estimate = 0.180, 95% CI 0.000–0.361 versus estimate = − 0.005, 95% CI –0.074–0.064 for HW02 (events); estimate = 0.186, 95% CI − 0.016–0.387 versus estimate = − 0.026, 95% CI − 0.123–0.071 for HW05 (events)] (Table S10). No clear effect modification by age, sex, or geographic region was observed. Sensitivity analyses showed that the association between heatwave exposure and respiratory sarcopenia remained broadly consistent after excluding participants with missing baseline characteristics (Fig. 3A and B) or standardizing age and BMI (Fig. 3C and D).

Fig. 3

The results of sensitivity analysis. Association between heatwave exposure and respiratory sarcopenia after excluding participants with missing baseline characteristics in Model 3: (A) heatwave events, (B) heatwave days. Association between heatwave exposure and respiratory sarcopenia after standardizing for age and BMI in Model 3: (C) heatwave events, (D) heatwave days. OR, odds ratio; CI, confidence interval; BMI, body mass index.

Conclusion

This prospective cohort study found that increased heatwave exposure, assessed as the difference between 2011 and 2015, was associated with higher odds of incident PEFR-based respiratory sarcopenia. Subgroup analyses suggested that individuals with BMI < 23 and chronic lung disease may be more susceptible. Additional analyses showed that heatwave exposure was more consistently associated with PEFR than with estimated muscle mass, which is compatible with, but does not prove, a lung-function-related pathway.

These results add to environmental epidemiology evidence that extreme heat is associated with adverse respiratory outcomes. Prior studies have reported associations between heatwaves and respiratory outpatient visits, respiratory mortality, and declines in lung function, often attributing these patterns to heat-related airway inflammation, oxidative stress, dehydration, and increased ventilatory workload3,4,5,6,7,8. In contrast, the sarcopenia literature has focused mainly on aging, chronic disease, nutrition, and physical function rather than climate-related exposures9,10,11,12,13. Our study connects these two areas by examining PEFR-based respiratory sarcopenia as an outcome potentially sensitive to environmental heat exposure, while recognizing that the observational design precludes causal inference.

A potential biological explanation is that heat stress may impair respiratory function through dehydration, systemic inflammation, oxidative stress, or increased ventilatory demand, thereby reducing respiratory reserve without necessarily causing measurable loss of appendicular muscle mass (Fig. 4)16,17,18. Participants with BMI < 23 may have lower physiologic reserve, while those with chronic lung disease may experience greater airway resistance, hypoxemia, or respiratory workload during heat events. However, because inflammatory biomarkers and direct measures of respiratory muscle strength were unavailable, this pathway should be interpreted as a hypothesis rather than a demonstrated mechanism.

Fig. 4

Hypothesized pathway linking heatwave exposure to PEFR-based respiratory sarcopenia. The pathway is conceptual and was not directly tested because inflammatory biomarkers and direct respiratory muscle strength measures were unavailable. PEFR, peak expiratory flow rate.

From a public health perspective, the findings suggest that heatwave adaptation strategies may need to consider respiratory muscle-related vulnerability in addition to conventional cardiorespiratory outcomes. Cooling interventions, air quality protection, and clinical monitoring during extreme heat may be especially relevant for individuals with low BMI or chronic lung disease. These implications should be interpreted cautiously given the observational design and the possibility of residual confounding.

Key strengths of this study include its prospective design, the focus on incident respiratory sarcopenia over four years, and the evaluation of multiple heatwave definitions. The inclusion of PEFR and estimated muscle mass analyses provided additional context for interpreting whether the observed associations were more closely linked to respiratory function or muscle mass. Subgroup and sensitivity analyses also helped assess whether findings were consistent across participant characteristics and analytic assumptions.

Several limitations should be noted. First, PEFR was used as a surrogate indicator of respiratory muscle strength because direct measures such as maximal inspiratory pressure, maximal expiratory pressure, or respiratory muscle endurance were unavailable. PEFR can be influenced by chronic lung disease, airway obstruction, acute respiratory conditions, and participant effort, which may have introduced outcome misclassification. Second, heatwave exposure was assessed at the city level rather than the individual level, which may have introduced exposure misclassification because indoor temperature, cooling access, occupational exposure, time-activity patterns, and short-term mobility were not captured. Third, the study period overlapped with a period of severe haze pollution in China. Air pollutants such as PM2.5, ozone, and nitrogen dioxide may co-vary with heat and independently affect lung function; insufficient control for these environmental confounders may have biased the observed associations. Fourth, proxy interview status was not an exclusion criterion. Although objective measurements such as PEFR were obtained through standardized assessment procedures, some self-reported covariates may have been proxy-reported, which could introduce reporting bias or nondifferential misclassification of health status, behaviors, and socioeconomic characteristics. Fifth, the observed effect sizes were relatively small; consequently, the associations may be sensitive to residual confounding, exposure or outcome misclassification, and other unmeasured sources of bias. Sixth, although participants with respiratory sarcopenia at baseline were excluded, reverse causality cannot be fully ruled out because individuals with poorer baseline lung function, greater frailty, or chronic disease may have been more vulnerable to heatwave exposure and more likely to develop respiratory sarcopenia. Seventh, the use of multiple heatwave definitions increases the possibility of chance findings; therefore, the results should be interpreted according to the consistency of patterns across definitions and the prespecified primary definition rather than isolated statistical significance. Eighth, inflammatory biomarkers were unavailable, limiting mechanistic interpretation. Ninth, we did not explicitly model lag times between heatwave exposure and respiratory sarcopenia onset; the exposure window reflected the survey month and preceding 11 months, and shorter latency periods could not be distinguished. Finally, large-scale climate variability, including El Nino/La Nina events, may have influenced year-to-year heatwave patterns but was not explicitly modeled.

Future research should incorporate direct measurements of respiratory muscle strength, inflammatory biomarkers, individual-level and time-varying residential heat exposure, air pollution data, explicit lag structures, large-scale climate variability indicators such as El Niño-Southern Oscillation, and repeated annual exposure measures to clarify temporal and biological pathways. Studies in diverse populations are also needed to assess generalizability and to determine whether lung function decline mediates the association between heatwave exposure and respiratory sarcopenia.

References

  1. Perkins-Kirkpatrick, S. E. & Lewis, S. C. Increasing trends in regional heatwaves. Nat. Commun. 11(1), 3357. https://doi.org/10.1038/s41467-020-16970-7 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Romanello, M. et al. The 2023 report of the Lancet countdown on health and climate change: The imperative for a health-centred response in a world facing irreversible harms. Lancet 402(10419), 2346–2394. https://doi.org/10.1016/S0140-6736(23)01859-7 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sorensen, C. & Hess, J. Treatment and prevention of heat-related illness. N. Engl. J. Med. 387(15), 1404–1413. https://doi.org/10.1056/NEJMcp2210623 (2022).

    Article  PubMed  Google Scholar 

  4. Zhang, A. et al. Impact of heatwaves on daily outpatient visits of respiratory disease: A time-stratified case-crossover study. Environ. Res. 169, 196–205. https://doi.org/10.1016/j.envres.2018.10.034 (2019).

    Article  CAS  PubMed  Google Scholar 

  5. Quick, M. The impacts of extreme heat events on non-accidental, cardiovascular, and respiratory mortality: An analysis of 12 Canadian cities from 2000 to 2020. Health Rep. 35(6), 3–15. https://doi.org/10.25318/82-003-x202400600001-eng (2024).

    Article  PubMed  Google Scholar 

  6. Alari, A., Letellier, N. & Benmarhnia, T. Effect of different heat wave timing on cardiovascular and respiratory mortality in France. Sci. Total Environ. 892, 164543. https://doi.org/10.1016/j.scitotenv.2023.164543 (2023).

    Article  CAS  PubMed  Google Scholar 

  7. Cheng, J. et al. Cardiorespiratory effects of heatwaves: A systematic review and meta-analysis of global epidemiological evidence. Environ. Res. 177, 108610. https://doi.org/10.1016/j.envres.2019.108610 (2019).

    Article  CAS  PubMed  Google Scholar 

  8. De Sario, M., Katsouyanni, K. & Michelozzi, P. Climate change, extreme weather events, air pollution and respiratory health in Europe. Eur. Respir. J. 42(3), 826–843. https://doi.org/10.1183/09031936.00074712 (2013).

    Article  CAS  PubMed  Google Scholar 

  9. Sato, S. et al. Respiratory sarcopenia: A position paper by four professional organizations. Geriatr. Gerontol. Int. 23(1), 5–15. https://doi.org/10.1111/ggi.14519 (2023).

    Article  PubMed  Google Scholar 

  10. Miyazaki, S., Tamaki, A., Wakabayashi, H. & Arai, H. Definition, diagnosis, and treatment of respiratory sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 27(3), 210–218. https://doi.org/10.1097/MCO.0000000000001003 (2024).

    Article  CAS  PubMed  Google Scholar 

  11. Nagano, A. et al. Respiratory sarcopenia and sarcopenic respiratory disability: Concepts, diagnosis, and treatment. J. Nutr. Health Aging 25(4), 507–515. https://doi.org/10.1007/s12603-021-1587-5 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dent, E., Woo, J., Scott, D. & Hoogendijk, E. O. Toward the recognition and management of sarcopenia in routine clinical care. Nat. Aging 1(11), 982–990. https://doi.org/10.1038/s43587-021-00136-1 (2021).

    Article  PubMed  Google Scholar 

  13. Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 48(1), 16–31. https://doi.org/10.1093/ageing/afy169 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Romanello, M. et al. The 2024 report of the Lancet Countdown on health and climate change: Facing record-breaking threats from delayed action. Lancet 404(10465), 1847–1896. https://doi.org/10.1016/S0140-6736(24)01822-1 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gea, J., Ausin, P., Martinez-Llorens, J. M. & Barreiro, E. Respiratory muscle senescence in ageing and chronic lung diseases. Eur. Respir. Rev. https://doi.org/10.1183/16000617.0087-2020 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bouchama, A. & Knochel, J. P. Heat stroke. N. Engl. J. Med. 346(25), 1978–1988. https://doi.org/10.1056/NEJMra011089 (2002).

    Article  CAS  PubMed  Google Scholar 

  17. Luo, Q. et al. Shikonin prevents mice from heat stroke-induced death via suppressing a trigger IL-17A on the inflammatory and oxidative pathways. Biomed. Pharmacother. 166, 115346. https://doi.org/10.1016/j.biopha.2023.115346 (2023).

    Article  CAS  PubMed  Google Scholar 

  18. Sekiguchi, Y. et al. Change in interleukin (IL)-6, 8, and 10 and its association with an increase in core temperature following a 7-mile running race in the warm weather. Res. Sports Med. 33(1), 107–116. https://doi.org/10.1080/15438627.2024.2428602 (2025).

    Article  PubMed  Google Scholar 

  19. Zhao, Y., Hu, Y., Smith, J. P., Strauss, J. & Yang, G. Cohort profile: The China Health and Retirement Longitudinal Study (CHARLS). Int. J. Epidemiol. 43(1), 61–68. https://doi.org/10.1093/ije/dys203 (2014).

    Article  PubMed  Google Scholar 

  20. Kera, T. et al. Definition of respiratory sarcopenia with peak expiratory flow rate. J. Am. Med. Dir. Assoc. 20(8), 1021–1025. https://doi.org/10.1016/j.jamda.2018.12.013 (2019).

    Article  PubMed  Google Scholar 

  21. Wen, X., Wang, M., Jiang, C. M. & Zhang, Y. M. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac. J. Clin. Nutr. 20(4), 551–556 (2011).

    PubMed  Google Scholar 

  22. Yang, M. et al. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: A prospective study. J. Cachexia Sarcopenia Muscle 8(2), 251–258. https://doi.org/10.1002/jcsm.12163 (2017).

    Article  PubMed  Google Scholar 

  23. Liu, Y., Cui, J., Cao, L., Stubbendorff, A. & Zhang, S. Association of depression with incident sarcopenia and modified effect from healthy lifestyle: The first longitudinal evidence from the CHARLS. J. Affect. Disord. 344, 373–379. https://doi.org/10.1016/j.jad.2023.10.012 (2024).

    Article  PubMed  Google Scholar 

  24. Alexandre, T. S., Duarte, Y. A., Santos, J. L., Wong, R. & Lebrao, M. L. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J. Nutr. Health Aging 18(8), 751–756. https://doi.org/10.1007/s12603-014-0540-2 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Liu, J., Shi, C., Sun, S., Liang, J. & Yang, Z.-L. Improving land surface hydrological simulations in China using CLDAS meteorological forcing data. J. Meteorol. Res. 33(6), 1194–1206. https://doi.org/10.1007/s13351-019-9067-0 (2019).

    Article  Google Scholar 

  26. Han, S. et al. Evaluation of CLDAS and GLDAS datasets for near-surface air temperature over major land areas of China. Sustainability 12(10), 4311 (2020).

    Article  Google Scholar 

  27. Tie, R. et al. CLDASSD: Reconstructing fine textures of the temperature field using super-resolution technology. Adv. Atmos. Sci. 39(1), 117–130. https://doi.org/10.1007/s00376-021-0438-y (2022).

    Article  Google Scholar 

Download references

来源:Nature 健康护理主题 · nature.com